New study shows XBB.1.5 COVID-19 vaccine significantly reduces hospitalizations and ICU admissions in older adults

Study evaluates the effectiveness of the XBB.1.5 COVID-19 vaccine in reducing hospitalizations and ICU admissions among vaccinated adults aged 60 and over in the Netherlands, showing a 70.7% effectiveness against hospitalization and 73.3% against ICU admission.

New discovery could reduce arsenic contamination in water

A study led by the University of Bristol shedding new light on how arsenic can be made less dangerous to humans has the potential to

October 30, 2024

Curaleaf Q2 Revenue Lifts 1% Sequentially

Curaleaf Reports Second Quarter 2023 Results Second quarter 2023 revenue of $339 million, representing an increase of 4% year-over-year, and adjusted EBITDA¹ of $70 million

August 10, 2023

Elevated metal levels in plasma and urine associated with greater ALS risk and shorter survival

People with higher levels of metals found in their blood and urine may be more likely to be diagnosed with -; and die from -;

August 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.